Herter, S., Emperador, M., Smyrilli, K., Kocher, D., Çelikyürekli, S., Zeiser, C., . . . Oehme, I. (2025). High content-imaging drug synergy screening identifies specific senescence-related vulnerabilities of mesenchymal neuroblastomas. Cell death & disease, 16, . https://doi.org/10.1038/s41419-025-07933-1
Chicago-Zitierstil (17. Ausg.)Herter, Sonja, et al. "High Content-imaging Drug Synergy Screening Identifies Specific Senescence-related Vulnerabilities of Mesenchymal Neuroblastomas." Cell Death & Disease 16 (2025). https://doi.org/10.1038/s41419-025-07933-1.
MLA-Zitierstil (9. Ausg.)Herter, Sonja, et al. "High Content-imaging Drug Synergy Screening Identifies Specific Senescence-related Vulnerabilities of Mesenchymal Neuroblastomas." Cell Death & Disease, vol. 16, 2025, https://doi.org/10.1038/s41419-025-07933-1.